EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Treatment of hyperphagia and obesity in Prader–Willi syndrome

Charlotte Höybye iD, Janice Forster iD, Anthony P Goldstone iD, Linda Gourash iD, Jennifer Miller, Maithé Tauber iD

Journal of Internal Medicine · 15.10.2026

DOI: 10.1111/joim.70173 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Internal Medicine, online erschienen am 15.10.2026. Verfasst von Charlotte Höybye und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Karolinska University Hospital, Stockholm, Sweden. Die Arbeit nennt 159 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prader–Willi syndrome (PWS) is a rare, neurodevelopmental, multisystemic syndrome caused by lack of expression of paternal genes on chromosome 15q11.2–13. PWS is characterized by muscular hypotonia, abnormal body composition, hormone deficiencies, cognitive dysfunction and behavioural issues, including hyperphagia, increasing the risk of severe obesity. A single causative gene for hyperphagia has not been identified, and regulation of hunger and satiety is complex and multifactorial, making it difficult to identify a specific neuropeptide or hormone as the most important. Cornerstone treatments are a strict, controlled diet and regular physical activity. Several clinical trials with different pharmacological agents have been performed attempting to reduce or treat hyperphagia and obesity. However, many drug programmes have been discontinued due to adverse events or not reaching endpoints. In this review, we have focused on phenomenology and management of hyperphagia, treatment with oxytocin (OT), glucagon‐like‐peptide‐1 receptor agonists (GLP‐1RA) and diazoxide choline. We conclude that controlled food access is crucial; managing expectations about food mitigates food‐related behaviour; OT treatment of infants with PWS results in less severe hyperphagia at ages 3 and 4 years old; and that the effects of GLP‐1RA on body weight seem modest. Studies of diazoxide choline extended‐release (DCCR), the first approved treatment of hyperphagia in PWS, have shown promising results, particularly in managing severe hyperphagia, reducing fat mass and improving behavioural issues. Thus, although progress is being made in targeted pharmacological therapies to control hyperphagia, controlled food access remains crucial to prevent obesity but is not sufficient for management of food and behaviour.

Schlagwörter

Stichwörter der Autor:innen

Prader–Willi syndromehyperphagiaobesity

Autor:innen und Institutionen

  • Department of Endocrinology, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
  • The Pittsburgh Partnership, specialists in PWS, Pittsburgh, Pennsylvania, USA.
  • PsychoNeuroEndocrinology Research Group, Division of Psychiatry, Department of Brain Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, UK.
  • Department of Pediatrics, Division of Endocrinology, University of Florida, Gainesville, Florida, USA.
  • Department of Pediatric Endocrinology, Hôpital des Enfants, CHU Toulouse, Toulouse, France.

ORCID-Profile: Charlotte Höybye, Janice Forster, Anthony P Goldstone, Linda Gourash, Maithé Tauber

Zitieren

APA

Höybye, C., Forster, J., Goldstone, A. P., Gourash, L., Miller, J., & Tauber, M. (2026). Treatment of hyperphagia and obesity in Prader–Willi syndrome. Journal of Internal Medicine. https://doi.org/10.1111/joim.70173

Vancouver

Höybye C, Forster J, Goldstone AP, Gourash L, Miller J, Tauber M. Treatment of hyperphagia and obesity in Prader–Willi syndrome. Journal of Internal Medicine. 2026. doi:10.1111/joim.70173

BibTeX
@article{Hybye2026,
  author = {Höybye, Charlotte and Forster, Janice and Goldstone, Anthony P and Gourash, Linda and Miller, Jennifer and Tauber, Maithé},
  title = {Treatment of hyperphagia and obesity in Prader–Willi syndrome},
  journal = {Journal of Internal Medicine},
  year = {2026},
  doi = {10.1111/joim.70173}
}
Kostenlos starten →